|1.||Manning, Warren J: 29 articles (01/2016 - 04/2004)|
|2.||Pennell, Dudley J: 29 articles (05/2015 - 01/2003)|
|3.||Naganawa, Shinji: 26 articles (11/2015 - 03/2007)|
|4.||Nakashima, Tsutomu: 24 articles (01/2014 - 03/2007)|
|5.||Arai, Andrew E: 23 articles (01/2016 - 02/2002)|
|6.||Sone, Michihiko: 23 articles (11/2015 - 03/2007)|
|7.||Nagel, Eike: 22 articles (12/2015 - 01/2002)|
|8.||Lombardi, Massimo: 22 articles (10/2015 - 01/2005)|
|9.||Prasad, Sanjay K: 22 articles (12/2014 - 01/2005)|
|10.||Bluemke, David A: 21 articles (02/2016 - 05/2005)|
01/01/1991 - "MRI, with its excellent contrast on T2 weighted and post-gadolinium sequences, is superior to CT for delineating tumor extension, the information essential for appropriate surgical intervention. "
03/01/2008 - "The image quality for T1-weighted, gadolinium-enhanced tumors was sufficiently good to enable us to evaluate the extent of tumor resection, whereas the T2-weighted image quality must be improved. "
03/01/2000 - "It is concluded that in our group of patients with hypervascular liver tumors and normal cardiac function, no significant improvement in tumor-to-liver contrast and enhancement during the arterial phase was found when gadolinium-enhanced magnetic resonance imaging was performed with a tailored scanning delay rather than with a fixed delay."
12/28/2013 - "7T T1w MRI at week 4 was able to detect non-leaky 100 μm sized lesions and leaky tumors with diameters down to 200 μm after contrast injection at week 5. PET imaging showed that (18)F-FLT (MW 244 Da) accumulated in the brain at week 4. Gadolinium-based MRI tracers (MW 559 Da and 2.066 kDa) extravasated after 5 weeks (tumor diameter 600 μm), and the lower MW agent cleared more rapidly from the tumor (mean apparent permeabilities 2.27 × 10(-5)cm/s versus 1.12 × 10(-5)cm/s). "
01/01/2010 - "These results indicate that while the ITC component is the ultimate barrier to cure for GBM, the pattern of spread and volumes of gadolinium-enhancing solid tumor are more robust indicators of prognosis."
01/01/2010 - "The new gold standard for myocardial viability assessment is late gadolinium enhancement-cardiovascular magnetic resonance (LGE-CMR); this technique has demonstrated that the transmural extent of scar predicts segmental functional recovery. "
07/01/2015 - "Super-resolution reconstruction of late gadolinium-enhanced MRI for improved myocardial scar assessment."
02/01/2015 - "Late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) imaging is the gold standard for myocardial scar evaluation. "
05/01/2014 - "The addition of first-pass stress perfusion and late gadolinium enhancement (scar) further improved diagnostic confidence (sensitivity 82.4%, specificity 95.8%, positive predictive value 93.3%, negative predictive value 88.5%, and diagnostic accuracy 90.2%). "
01/01/2014 - "Subsequently a clinical protocol was developed, to assess the feasibility of scar tissue detection with native T(1ρ)-mapping in patients (n = 21) with chronic MI, and correlated with gold standard late gadolinium enhancement (LGE) CMR. "
|3.||Neoplasm Metastasis (Metastasis)
12/01/2008 - "Gadolinium-enhanced three-dimensional magnetization-prepared rapid gradient-echo (3D MP-RAGE) imaging is superior to spin-echo imaging in delineating brain metastases."
11/01/2011 - "DW MR imaging is superior to T2WFSE imaging and equivalent to gadolinium chelate-enhanced MR imaging for the preoperative detection of hepatic metastases. "
09/01/2014 - "Single dose gadolinium (Gd) enhanced fluid-attenuated inversion recovery (FLAIR) is helpful for visualizing superficial parenchymal metastases. "
01/01/2005 - "Our results showed that the addition of T2-weighted fast SE imaging to gadolinium-enhanced GRE imaging improved the observer performance in the detection of metastases."
03/01/1997 - "Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging?"
11/08/2005 - "Gadolinium enhancement is often used in randomized clinical trials to evaluate the efficacy of new drugs in multiple sclerosis (MS). "
11/01/2000 - "Gadolinium (Gd)-enhanced MR imaging has greatly improved the understanding of the pathophysiology of multiple sclerosis (MS) and has provided robust outcome measures for monitoring MS activity. "
08/01/1997 - "To compare the efficacy of single-dose gadolinium with magnetization transfer contrast (MTC) with that of triple-dose gadolinium in detecting enhancing multiple sclerosis lesions. "
07/01/1994 - "Administration of triple-dose gadolinium provides increased lesion conspicuity and an improved lesion detection rate when compared to single-dose gadolinium in patients with multiple sclerosis."
03/01/2015 - "Studies of patients with multiple sclerosis suggest that MRI using SPIONs may have increased sensitivity over gadolinium for plaque detection. "
|5.||Acoustic Neuroma (Acoustic Neurinoma)
12/01/1991 - "The early diagnosis of acoustic neuromas with the use of gadolinium-enhanced MRI may lead to better outcome following surgery. "
10/01/1998 - "Fast spin echo magnetic resonance imaging techniques without gadolinium have been shown to be as effective in the detection of acoustic neuroma as contrast-enhanced magnetic resonance imaging. "
03/01/2000 - "Gadolinium enhanced MRI is the gold standard investigation for the detection of acoustic neuroma. "
09/01/1999 - "The improved cost-effectiveness of gadolinium-enhanced magnetic resonance imaging (MRIg) as a diagnostic tool for vestibular schwannoma has resulted in smaller tumours being diagnosed. "
07/01/1994 - "Gadolinium-enhanced magnetic resonance imaging (MRI) is currently the gold standard for diagnosis of an acoustic neuroma. "
|1.||Gadolinium DTPA (Magnevist)
|3.||Pentetic Acid (DTPA)
|6.||gadobenic acid (gadobenate dimeglumine)
|7.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|9.||Adrenal Cortex Hormones (Corticosteroids)
|10.||gadolinium ethoxybenzyl DTPA
|4.||Drug Therapy (Chemotherapy)